GlassScriptPhysician profile
Michelle L Beloff
NPI 1942382148
$846.82
in general payments reported to CMS, 2019-2025
22 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $234 · 2020: $67.95 · 2021: $39.53 · 2022: $187 · 2023: $191 · 2024: $13.35 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $279 · Education: $40.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $278.67 |
| Education | $40.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $162.99 | 2019-2025 | |
| Millicent US INC | $115.36 | 2019-2024 | Femring, Intrarosa |
| Exeltis, USA INC. | $69.10 | 2021-2023 | Slynd |
| Abbvie INC. | $56.63 | 2019-2023 | Lo Loestrin Fe |
| Lupin INC. | $55.75 | 2019-2020 | |
| Therapeuticsmd, INC. | $43.38 | 2019-2022 | |
| Organon LLC | $40.42 | 2021-2022 | |
| Astellas Pharma US INC | $35.78 | 2023 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $32.00 | 2023 | |
| Allergan, INC. | $29.85 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $29.21 | 2019 | |
| Minerva Surgical, INC | $26.40 | 2019-2021 | |
| Pfizer INC. | $16.87 | 2022 | |
| Covidien LP | $16.70 | 2019 | |
| Sumitomo Pharma America, INC. | $16.06 | 2023 | Myfembree |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $15.00 | 2022 | |
| Agile Therapeutics, INC. | $15.00 | 2022 | |
| Evofem Biosciences, INC. | $14.92 | 2022 | |
| Merck Sharp & Dohme LLC | $14.28 | 2019 | |
| Amag Pharmaceuticals, INC. | $14.00 | 2019 | |
| Coopersurgical, INC. | $13.61 | 2022 | |
| Avion Pharmaceuticals | $13.51 | 2023 | Balcoltra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Beloff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.